Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 1093
interventional 887
Observational 187
Registry 19

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 339
Procedure 82
Drug|Procedure 56
Biological 46
Device 44
Radiation 40
Drug|placebo 35
Drug|Other 29
Other 26
Drug|Radiation 18
Biological|Drug 17
Diagnostic Test 14
Procedure|Radiation 14
Device|Drug 12
Combination Product 9
Behavioral 8
Genetic 8
Biological|Drug|Other 7
Biological|Procedure 5
Combination Product|Drug 5
Device|Radiation 5
Drug|Other|placebo 5
Drug|Procedure|Radiation 5
Device|Procedure 4
Biological|Other 3
Biological|Other|placebo 3
Biological|placebo 3
Biological|Radiation 3
Device|Drug|Procedure 3
Device|Other 3
Dietary Supplement|placebo 3
Drug|placebo|Procedure 3
Other|Procedure 3
Other|Procedure|Radiation 3
Other|Radiation 3
Biological|Device 2
Diagnostic Test|Drug 2
Drug|Other|Procedure 2
Behavioral|Other 1
Biological|Combination Product 1
Biological|Drug|placebo 1
Biological|Drug|placebo|Procedure 1
Biological|Drug|Procedure 1
Biological|Other|Radiation 1
Combination Product|Procedure 1
Device|Drug|Other|Procedure 1
Diagnostic Test|Drug|Procedure 1
Dietary Supplement|Drug|Other 1
Dietary Supplement|Drug|Procedure 1
Dietary Supplement|Other 1
Drug|Genetic 1
Drug|Genetic|Procedure 1
Drug|Other|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
China 233
United States 220
Korea, Republic of 55
Taiwan 40
France 38
NA 26
Hong Kong 18
Canada 17
Japan 17
Germany 15
Italy 13
Singapore 8
Spain 8
United Kingdom 7
Brazil 6
China|Korea, Republic of|Taiwan 4
Egypt 4
India 3
Japan|Korea, Republic of 3
United States|Canada 3
United States|Germany 3
United States|Taiwan 3
Australia|New Zealand 2
Austria 2
Israel 2
Korea, Republic of|Taiwan 2
Netherlands 2
Sudan 2
Thailand 2
United States|Hong Kong|Taiwan 2
United States|Spain 2
Australia 1
Austria|France|Germany|Hungary|Netherlands|Poland|Romania|United Kingdom 1
Austria|France|Germany|Switzerland 1
Austria|Germany|Korea, Republic of|Switzerland 1
Belgium 1
Belgium|Canada|France|Spain|United Kingdom 1
Belgium|Germany|Italy|Spain|United Kingdom 1
Belgium|United Kingdom 1
Belgium|United States|Canada|France|Italy|Korea, Republic of|Singapore|Spain|Taiwan 1
Canada|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Taiwan 1
China|France|Germany|Italy|Poland|Spain|Taiwan|United Kingdom 1
China|Hong Kong|Japan|Korea, Republic of|Singapore|Taiwan|Thailand 1
China|Hong Kong|Korea, Republic of|Malaysia|Taiwan 1
China|Hong Kong|Korea, Republic of|Taiwan 1
China|Hong Kong|Korea, Republic of|Taiwan|Thailand 1
China|Hong Kong|Singapore|Taiwan|Thailand 1
China|Korea, Republic of|Taiwan|Thailand 1
China|Taiwan|Thailand 1
China|United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|Mexico|New Zealand|Portugal|Romania|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
China|United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Mexico|Netherlands|New Zealand|Puerto Rico|Romania|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
Croatia|Hong Kong|India|Korea, Republic of|Malaysia|Philippines|Poland|Serbia|Singapore|Sweden|Thailand 1
Czechia|France|Germany|Italy|Poland|Spain 1
Denmark 1
France|Germany|Italy|Spain 1
France|Germany|Spain 1
France|Korea, Republic of|Taiwan 1
Germany|Italy 1
Germany|Italy|Korea, Republic of|Spain 1
Germany|Spain 1
Germany|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|Croatia|France|Greece|Israel|Italy|Mexico|New Zealand|Peru|Poland|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
Greece|Israel|Italy 1
Greece|Spain|Switzerland 1
Hong Kong|Korea, Republic of 1
Hong Kong|Korea, Republic of|Singapore|Taiwan 1
Hong Kong|Singapore|Taiwan 1
Hong Kong|Taiwan|Thailand 1
Japan|Korea, Republic of|Taiwan|Hong Kong 1
Japan|United States|Argentina|Australia|Canada|China|France|Hong Kong|Italy|Korea, Republic of|Spain|Taiwan|Thailand 1
Japan|United States|Australia|Brazil|Canada|China|France|Hong Kong|India|Italy|Korea, Republic of|Mexico|Russian Federation|Singapore|Spain|Taiwan|Thailand|Vietnam 1
Korea, Republic of|Malaysia|Myanmar|Singapore 1
Mongolia 1
Pakistan 1
Philippines 1
Poland 1
Saudi Arabia 1
Singapore|Taiwan|United Kingdom 1
Spain|Taiwan|United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|France|Germany|Greece|Hong Kong|Israel|Italy|Korea, Republic of|New Zealand|Peru|Poland|Russian Federation|Singapore|South Africa|United Kingdom 1
Spain|United States|Australia|Austria|Belgium|Canada|China|France|Germany|Italy|Korea, Republic of|Singapore|Taiwan 1
Sweden 1
Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|China|Czechia|France|Germany|Greece|Hong Kong|Italy|Japan|Korea, Republic of|New Zealand|Poland|Puerto Rico|Romania|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Colombia|Czechia|France|Georgia|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Philippines|Poland|Romania|Russian Federation|Singapore|Spain|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Italy|Netherlands|New Zealand|Portugal|Spain|Sweden|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Brazil|China|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czech Republic|France|Germany|Hong Kong|India|Italy|Japan|Korea, Republic of|Mexico|Poland|Puerto Rico|Russian Federation|South Africa|Spain|Sweden|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Argentina|Australia|Belgium|Canada|China|Denmark|France|Germany|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Malaysia|New Zealand|Norway|Poland|Russian Federation|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Canada|Hong Kong|Russian Federation|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Czech Republic|Finland|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Norway|Philippines|Portugal|Romania|Spain|Sweden|Switzerland|Taiwan|Thailand 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Poland|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Japan|Czechia|France|Germany|Hong Kong|Italy|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|Turkey 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|France|Germany|Greece|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Spain|Taiwan|Thailand 1
United States|Australia|Austria|Brazil|Canada|China|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Peru|Puerto Rico|Taiwan|Thailand|Turkey 1
United States|Australia|Belgium|Canada|China|France|Germany|Hong Kong|Israel|Italy|Japan|Korea, Republic of|Malaysia|Philippines|Poland|Russian Federation|Singapore|Spain|Taiwan|Thailand|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Hong Kong|Ireland|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Singapore|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Canada 1
United States|Australia|Canada|Chile|China|Colombia|France|Germany|Ireland|Italy|Japan|Korea, Republic of|Mexico|New Zealand|Poland|Russian Federation|Spain|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Australia|Canada|China|Czechia|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|China|France|Germany|Hong Kong|Israel|Italy|Korea, Republic of|New Zealand|Portugal|Singapore|Taiwan|Thailand|United Kingdom 1
United States|Australia|Canada|Hong Kong|Korea, Republic of 1
United States|Australia|Canada|New Zealand|Puerto Rico 1
United States|Australia|Chile|Colombia|Denmark|Israel|Japan|Korea, Republic of|New Zealand|Puerto Rico|Taiwan|Turkey|Ukraine 1
United States|Australia|France|Germany|Italy|New Zealand|Spain 1
United States|Austria|Belgium|China|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|New Zealand|Singapore|Spain|Switzerland|Taiwan|Thailand|Turkey|United Kingdom 1
United States|Austria|Belgium|Czechia|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|New Zealand|Spain|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Austria|Belgium|Egypt|France|Germany|Hungary|Italy|Lebanon|Spain|Turkey 1
United States|Austria|Belgium|Germany|Korea, Republic of|Spain|Switzerland 1
United States|Austria|Canada|Germany|Hong Kong|Italy|Japan|Switzerland|Taiwan 1
United States|Belgium 1
United States|Belgium|Canada|China|France|Germany|Italy|Korea, Republic of|Netherlands|Singapore|Spain|United Kingdom 1
United States|Belgium|Canada|France|Germany|Ireland|Italy|Korea, Republic of|Spain|Switzerland|United Kingdom 1
United States|Belgium|Canada|Germany|Italy 1
United States|Belgium|China|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Slovakia|Taiwan|United Kingdom 1
United States|Belgium|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|New Zealand|Singapore|Spain|Taiwan|United Kingdom 1
United States|Belgium|France|Greece|Italy 1
United States|Belgium|France|Israel|Italy 1
United States|Belgium|Italy|Spain|Ukraine|United Kingdom 1
United States|Brazil|Canada|China|France|Germany|Hong Kong|India|Italy|Japan|Korea, Republic of|Russian Federation|Spain|Taiwan|Thailand|Ukraine|Vietnam 1
United States|Bulgaria|Israel|Romania|Serbia 1
United States|Canada|China|Germany|Hong Kong|Italy|Korea, Republic of|Malaysia|Philippines|Singapore|Spain|Taiwan|Thailand|Vietnam 1
United States|Canada|China|Hong Kong|Italy|Japan|Korea, Republic of|Malaysia|Philippines|Taiwan|Thailand 1
United States|Canada|China|Korea, Republic of|Singapore|Taiwan 1
United States|Canada|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Puerto Rico|Singapore|Spain|Taiwan|United Kingdom 1
United States|Canada|France|Germany|Hong Kong|Korea, Republic of|Taiwan 1
United States|Canada|Germany|Hong Kong|Italy|Japan|Spain|Taiwan 1
United States|Canada|Hong Kong|Italy|Korea, Republic of|Puerto Rico|Spain|Taiwan|United Kingdom 1
United States|Canada|Korea, Republic of 1
United States|Canada|Puerto Rico 1
United States|Canada|Singapore|Taiwan 1
United States|Canada|United Kingdom 1
United States|China|Czechia|France|Germany|Italy|Japan|Poland|Spain|Taiwan|United Kingdom 1
United States|China|France|Germany|Hong Kong|Italy|Korea, Republic of|Singapore|Spain|Switzerland|Taiwan|United Kingdom 1
United States|China|Hong Kong|Italy|Japan|Korea, Republic of|Singapore|Spain|Taiwan 1
United States|China|Hong Kong|Taiwan 1
United States|China|Italy|Korea, Republic of|Taiwan|United Kingdom 1
United States|France 1
United States|France|Germany|Israel|Italy|Korea, Republic of|Spain|Taiwan 1
United States|France|Germany|Spain 1
United States|France|Hong Kong|Korea, Republic of|Malaysia|Philippines|Singapore|Taiwan 1
United States|France|Italy|Japan|Russian Federation|Spain|United Kingdom 1
United States|France|Italy|Spain 1
United States|France|Spain 1
United States|France|Spain|United Kingdom 1
United States|Germany|Poland|Puerto Rico|Romania|Russian Federation|Ukraine 1
United States|Hong Kong|Korea, Republic of|Taiwan 1
United States|Hong Kong|Singapore|Taiwan 1
United States|Italy|Spain 1
United States|Italy|Taiwan|United Kingdom 1
United States|Japan 1
United States|Japan|Korea, Republic of|Taiwan 1
United States|New Zealand|Spain 1
United States|Puerto Rico 1
United States|Singapore 1
United States|Singapore|Taiwan|United Kingdom 1
Vietnam 1

Sites per Study

Site_count Study_Count
1 558
2 43
3 53
4 22
5 20
6 23
7 20
8 8
9 11
10 7
11 7
12 5
13 2
14 3
15 7
16 2
17 6
18 1
20 2
21 2
22 1
23 6
24 5
26 3
28 4
29 2
31 1
33 1
34 2
35 1
38 2
39 1
40 1
41 2
43 3
44 2
51 1
57 1
59 1
61 2
65 1
66 1
70 1
73 1
75 1
77 1
79 1
92 2
94 2
104 1
107 1
113 1
121 1
127 1
131 2
134 1
142 1
143 2
146 1
147 1
172 1
173 2
177 1
178 1
182 1
188 1
193 1
194 1
199 1
204 1
218 2
241 1
281 1
295 1
333 1
673 1
1329 1

Phase

Phase Study_Count
Phase 2 258
N/A 201
Phase 1 141
Phase 3 121
Phase 1/Phase 2 93
Phase 4 38
Phase 2/Phase 3 21
Early Phase 1 14

Number of Arms

Number_of_Arms Count_of_Studies
1 413
2 359
3 42
4 17
5 10
6 6
7 1
8 1
9 1
10 1
14 1
37 1
NA 34

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 1.00000 2.0000 2.00000 5.00000 2.000 25.0000 13.000 1.0000
1st Qu. 11.50000 30.0000 15.00000 28.00000 30.000 86.0000 180.000 52.5000
Median 22.50000 80.0000 24.00000 52.00000 47.000 120.0000 292.000 120.0000
Mean 43.78571 235.2935 41.02128 91.04301 105.498 249.4762 382.405 164.0789
3rd Qu. 27.00000 178.0000 45.00000 97.00000 88.000 246.0000 530.000 200.0000
Max. 300.00000 12380.0000 300.00000 1097.00000 6452.000 1220.0000 1714.000 1044.0000

Trial Group Type

group_type Group_Count
Experimental 1071
Active Comparator 253
Other 65
Placebo Comparator 55
No Intervention 49
NA 34
Sham Comparator 3

Intervention Model

intervention_model Study_Count
Single Group Assignment 451
Parallel Assignment 399
Sequential Assignment 22
Crossover Assignment 6
Factorial Assignment 6
NA 3

Primary Purpose

primary_purpose Study_Count
Treatment 749
Diagnostic 54
Prevention 27
Other 15
Screening 11
Supportive Care 10
Basic Science 9
Health Services Research 5
NA 5
Device Feasibility 2

Observational Studies

Studies by Country

Country Study_Count
United States 32
NA 26
China 22
France 13
Italy 11
Taiwan 10
Korea, Republic of 9
Germany 8
Egypt 5
Japan 5
Spain 4
Canada 3
Switzerland 3
United States|Canada 2
Argentina|France 1
Australia 1
Australia|China|Hong Kong|Japan|Korea, Republic of|New Zealand|Singapore|Taiwan|Thailand 1
Austria|Brazil|Canada|China|Czechia|Denmark|Egypt|France|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Japan|Kazakhstan|Korea, Republic of|Mexico|Netherlands|Pakistan|Poland|Russian Federation|Singapore|Slovakia|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Vietnam 1
Austria|Germany 1
Bangladesh 1
Belgium 1
Belgium|France 1
China|Hong Kong|Japan 1
Croatia 1
Czechia 1
Denmark 1
Gambia|Senegal 1
Greece 1
Hong Kong 1
India 1
Israel 1
Korea, Republic of|Taiwan 1
Malaysia|Philippines|Singapore|Thailand 1
Mexico 1
Singapore 1
Sweden 1
Taiwan|Thailand 1
Turkey 1
United Kingdom 1
United States|Argentina|Austria|Belgium|Canada|China|Denmark|Egypt|France|Greece|Italy|Japan|Korea, Republic of|Netherlands|Russian Federation|Saudi Arabia|Spain|Sweden|Taiwan|Thailand|Turkey 1
United States|Brazil|Canada|France|Germany|Greece|Italy|Sweden 1
United States|Canada|China|Colombia|Croatia|Czech Republic|Finland|France|Greece|Hong Kong|Hungary|India|Indonesia|Israel|Italy|Japan|Kazakhstan|Korea, Republic of|Libyan Arab Jamahiriya|Malaysia|Mexico|Norway|Pakistan|Philippines|Portugal|Qatar|Romania|Russian Federation|Singapore|Slovakia|Spain|Sweden|Syrian Arab Republic|Thailand|Ukraine|United Arab Emirates|Uruguay|Venezuela|Vietnam 1
United States|France|Germany|Italy|Netherlands|Saudi Arabia|Switzerland|Turkey 1
United States|France|Germany|Italy|Spain 1
United States|France|Germany|Italy|Spain|Taiwan|Thailand 1
United States|Italy 1
United States|Switzerland 1
Zambia 1

Sites per Study

Site_count Study_Count
1 144
2 12
3 3
4 2
5 2
6 4
7 1
9 2
10 1
13 1
14 1
15 1
17 1
26 1
30 1
31 1
34 1
37 1
42 1
46 1
48 1
60 1
66 1
75 1
82 1

Enrollment Metrics

Measure Observational
Min 2.000
1st Qu 56.250
Median 200.000
Mean 4691.215
3rd Qu 803.750
Max 741379.000

Observation Model

observational_model Study_Count
Cohort 120
Case-Control 20
Case-Only 20
Other 9
NA 9
Case Control 7
Case-Crossover 1
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 117
Retrospective 43
Other 13
Cross-Sectional 12
NA 2

Registries

Studies by Country

Country Study_Count
Korea, Republic of 4
United States 3
NA 2
Spain 2
Argentina 1
Austria 1
Belgium|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom 1
China 1
Denmark 1
France 1
Italy 1
United States|France|Germany|Italy|Spain 1

Sites per Study

Site_count Study_Count
1 12
5 2
6 1
8 1
27 1
37 1
70 1

Enrollment Metrics

Measure Registries
Min 10.000
1st Qu 186.500
Median 500.000
Mean 3562.368
3rd Qu 2005.000
Max 23124.000

Registry Model

observational_model Study_Count
Cohort 14
Case-Only 2
Case-Control 1
Other 1
NA 1

Time Perspective

time_perspective Study_Count
Prospective 18
NA 1

Follow-up

target_duration Study_Count
10 Years 4
3 Years 4
5 Years 2
1 Year 1
100 Years 1
12 Months 1
20 Years 1
24 Months 1
36 Months 1
6 Months 1
6 Years 1
62 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03405909 Standardized CEUS Algorithms for Diagnosis of HCC - Prospective German Multicenter Study https://ClinicalTrials.gov/show/NCT03405909 Recruiting University Hospital Erlangen 2020-02-29
NCT03356535 Metabolic Signature of Healthy Lifestyle and HCC https://ClinicalTrials.gov/show/NCT03356535 Completed International Agency for Research on Cancer 2017-09-15
NCT03356236 Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation https://ClinicalTrials.gov/show/NCT03356236 Recruiting Cancer Institute and Hospital, Chinese Academy of Medical Sciences 2020-11-30
NCT03300414 Biologic Basis of Liver Cancer From Chronic Hepatitis B https://ClinicalTrials.gov/show/NCT03300414 Completed University of California, Davis 2018-12-14
NCT03295006 A TheraSphere® Advanced Dosimetry Retrospective Global Study in HCC https://ClinicalTrials.gov/show/NCT03295006 Recruiting BTG International Inc. 2019-11-30
NCT03289273 Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC) https://ClinicalTrials.gov/show/NCT03289273 Active, not recruiting Bayer 2022-02-01
NCT03267641 Prospective Cohort Study on the Clinical Trajectory of Resected Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03267641 Recruiting National Cancer Centre, Singapore 2021-05-31
NCT03254121 Genome Studies of Hepatocellular Carcinoma Developed in Hepatitis C Patients With Sustained Virological Response https://ClinicalTrials.gov/show/NCT03254121 Recruiting Karolinska Institutet 2021-01-01
NCT03253536 Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03253536 Recruiting Ludwig-Maximilians - University of Munich 2022-07-10
NCT03200171 Effect of DAAs on Behavior of HCC in HCV Patients https://ClinicalTrials.gov/show/NCT03200171 Recruiting Al-Azhar University 2019-08-31
NCT03197155 Direct-acting Antivirals and Hepatocellular Carcinoma Recurrence https://ClinicalTrials.gov/show/NCT03197155 Completed Hospices Civils de Lyon 2017-01-31
NCT03163186 Transradial Versus Transfemoral Arterial Access in Liver Cancer Embolization: Randomized Trial to Assess Patient Outcomes and Satisfaction (BEST ACCESS Trial). https://ClinicalTrials.gov/show/NCT03163186 Completed Medical University of South Carolina 2016-04-20
NCT03162198 Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03162198 Completed Institute of Liver and Biliary Sciences, India 2018-10-31
NCT03088423 HCC Response Assessment by MRI After SBRT https://ClinicalTrials.gov/show/NCT03088423 Completed Institut de Cancérologie de Lorraine 2013-04-01
NCT03081637 FLNA in HCC Patients https://ClinicalTrials.gov/show/NCT03081637 Completed University of Milan 2014-12-31
NCT03071458 Mutational Landscape in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03071458 Completed Institut National de la Santé Et de la Recherche Médicale, France 2015-05-31
NCT03053596 LifePearl Anthracyclin Registry in Selective Chemo-Embolization of Patients With Unresectable HCC (PARIS Registry) https://ClinicalTrials.gov/show/NCT03053596 Completed Terumo Europe N.V. 2019-04-01
NCT03039322 Golgi Protein for HCC Diagnosis https://ClinicalTrials.gov/show/NCT03039322 Completed Ain Shams University 2015-12-30
NCT02990351 Efficacy of Loco-regional Treatment for Hepatocellular Carcinoma Prior to Living Donor Liver Transplantation in Egypt https://ClinicalTrials.gov/show/NCT02990351 Completed Ain Shams University 2015-12-31
NCT02967848 Liver Function Investigation With SPECT https://ClinicalTrials.gov/show/NCT02967848 Recruiting Royal North Shore Hospital 2019-12-31
NCT03232593 A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s) https://ClinicalTrials.gov/show/NCT03232593 Recruiting Hoffmann-La Roche 2023-01-11
NCT02941861 Factors Influencing the 3-Year Recurrence of Liver Carcinoma After Surgery https://ClinicalTrials.gov/show/NCT02941861 Completed Chulabhorn Hospital 2016-08-31
NCT02898415 Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT02898415 Completed Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 2016-03-31
NCT02880306 Hepatocellular Carcinoma and Rheumatoid Arthritis https://ClinicalTrials.gov/show/NCT02880306 Completed Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 2016-03-31
NCT02848638 Pair Production PET Imaging to Detect Particle Distribution in Patients Undergoing Yttrium-90 Radioembolization https://ClinicalTrials.gov/show/NCT02848638 Completed University of Washington 2016-03-31
NCT02838836 Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid Cancers https://ClinicalTrials.gov/show/NCT02838836 Recruiting University of Missouri-Columbia 2019-06-30
NCT02809287 A Novel Laparoscopic Hepatectomy Posture, Left Lateral Position Plus Jackknife Position https://ClinicalTrials.gov/show/NCT02809287 Completed Sun Yat-sen University 2016-01-31
NCT02786342 Italian Study Of Validation Of Angiogenesis Polymorphisms In HCC Patients Treated With Sorafenib https://ClinicalTrials.gov/show/NCT02786342 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2020-06-30
NCT02785835 Hepatocellular Carcinoma in HIV-infected Patients https://ClinicalTrials.gov/show/NCT02785835 Recruiting Hospital Universitario de Valme 2016-12-31
NCT02762721 Analysis of Oncogenes in Intrahepatic Cholangiocarcinoma or Mixed Hepatocellular-Cholangiocarcinoma in Tumor Tissue Samples https://ClinicalTrials.gov/show/NCT02762721 Completed ArQule 2017-04-06
NCT02757846 Radiomics of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02757846 Enrolling by invitation Chinese Academy of Sciences 2022-03-31
NCT02743065 HepaSphere Chemoembolization in Advanced HCC Patients: Safety & Efficacy Registry in China https://ClinicalTrials.gov/show/NCT02743065 Recruiting Fifth Affiliated Hospital, Sun Yat-Sen University 2019-06-30
NCT02730611 Metabolic Syndrome, Bile Acids, Hepatocellular Carcinoma and Cholangiocarcinoma https://ClinicalTrials.gov/show/NCT02730611 Completed Assistance Publique - Hôpitaux de Paris 2017-10-31
NCT02727673 Relationship Between Circulating Tumor Stem Cells and the Clinical Pathology https://ClinicalTrials.gov/show/NCT02727673 Completed Eastern Hepatobiliary Surgery Hospital 2014-08-31
NCT02724345 Postoperative Adjuvant TACE Treatment in CK18 Positive Patients https://ClinicalTrials.gov/show/NCT02724345 Completed Eastern Hepatobiliary Surgery Hospital 2015-06-30
NCT02685631 Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study https://ClinicalTrials.gov/show/NCT02685631 Recruiting Vanderbilt-Ingram Cancer Center 2021-08-31
NCT02670122 Prospective Study to Evaluate Safety of Deb-TACE With 100µ Beads in Patients With Non Resectable HCC https://ClinicalTrials.gov/show/NCT02670122 Completed Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 2018-11-30
NCT02643173 Hepatocellular Carcinoma Recurrence and Anesthesia https://ClinicalTrials.gov/show/NCT02643173 Completed Seoul National University Bundang Hospital 2019-06-30
NCT02616692 HCC Patient Preferences in Japan https://ClinicalTrials.gov/show/NCT02616692 Completed Bayer 2016-10-07
NCT02613156 Efficacy Analysis of Complete Laparoscopic Resection of Recurrent Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02613156 Completed Sun Yat-sen University 2015-10-31
NCT02587793 Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients https://ClinicalTrials.gov/show/NCT02587793 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2018-07-31
NCT02552745 Preventive Effects of Parecoxib on Postoperative Complications in Hepatocellular Carcinoma Patients Undergoing Hepatic Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT02552745 Completed Sun Yat-sen University 2015-03-31
NCT02541149 Annexin A2 as a Novel Diagnostic Marker in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02541149 Completed Ain Shams University 2015-06-30
NCT02489838 Lung Dose in Patients Treated With Yttrium-90 for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02489838 Completed University of Rochester 2019-08-07
NCT02412579 Genetic Profiling of Liver Cancer in Patients Undergoing Liver Transplantation https://ClinicalTrials.gov/show/NCT02412579 Active, not recruiting Baylor Research Institute 2020-05-15
NCT02372162 Fingerprint Characterization of Advanced HCC https://ClinicalTrials.gov/show/NCT02372162 Completed University Hospital Tuebingen 2019-06-01
NCT02366286 Hepatitis B and Hepatitis C as Risk Factors for Hepatocellular Carcinoma in African and Asian Immigrants https://ClinicalTrials.gov/show/NCT02366286 Active, not recruiting Mayo Clinic 2022-12-31
NCT02358070 Epidemiologic Study of Hepatocellular Carcinoma in the US https://ClinicalTrials.gov/show/NCT02358070 Completed Stanford University 2016-09-01
NCT02344680 Liver Fibrosis in Zambian HIV-HBV Co-infected Patients https://ClinicalTrials.gov/show/NCT02344680 Active, not recruiting University of Alabama at Birmingham 2024-08-31
NCT02329821 Change of Lactate Concentration During Hartmann Solution Infusion for Hepatic Resection https://ClinicalTrials.gov/show/NCT02329821 Completed Samsung Medical Center 2015-05-31
NCT02288910 Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver https://ClinicalTrials.gov/show/NCT02288910 Active, not recruiting Rush University Medical Center 2019-07-31
NCT02269995 Post-marketing Surveillance of DC Bead in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02269995 Completed Eisai Inc. 2015-05-14
NCT02272504 A Protocol of the Canadian Prospective Study for Hepatocellular Carcinoma Surveillance Using Biomarkers https://ClinicalTrials.gov/show/NCT02272504 Active, not recruiting Wako Life Sciences 2020-08-31
NCT02173119 Can Quantitative MRI After cTACE Help Predict Survival ? https://ClinicalTrials.gov/show/NCT02173119 Completed Medical College of Wisconsin 2018-03-07
NCT02156700 Quantitative Real-time Ultrasound Elastography for Characterisation of Liver Tumors https://ClinicalTrials.gov/show/NCT02156700 Completed University Hospital Dubrava 2015-12-31
NCT02129829 PROLIFICA - West African Treatment Cohort for Hepatitis B https://ClinicalTrials.gov/show/NCT02129829 Active, not recruiting Imperial College London 2020-04-01
NCT02113865 Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients https://ClinicalTrials.gov/show/NCT02113865 Completed Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 2014-10-31
NCT02093104 TACE Study-Liver Embolization Perfusion (VGH Radiology LIU) https://ClinicalTrials.gov/show/NCT02093104 Completed University of British Columbia 2016-04-30
NCT02073435 A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation https://ClinicalTrials.gov/show/NCT02073435 Completed Northwestern University 2015-05-31
NCT02061956 A Simple Prognostic Scoring System for Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02061956 Completed Sun Yat-sen University 2011-12-31
NCT01316679 An Analysis of Urinary Proteases as Biomarkers for Hepatocellular Carcinoma-101423 https://ClinicalTrials.gov/show/NCT01316679 Completed Vanderbilt University Medical Center 2013-01-31
NCT02056041 Selection Criteria for Safe Hepatectomy for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02056041 Completed University of Milan 2013-12-31
NCT01957618 The Follow-up Study of Chronic Hepatitis B Patients With Liver Cirrhosis Receiving Anti-HBV Therapy https://ClinicalTrials.gov/show/NCT01957618 Enrolling by invitation National Taiwan University Hospital 2012-01-31
NCT01937286 Single Center Experience Over a Decade in Living Donor Liver Transplantation for Egyptian Patients With Hepatocellular Carcinoma: Stretching the Limits https://ClinicalTrials.gov/show/NCT01937286 Completed Ain Shams University 2011-12-31
NCT01933945 Outcomes of HCC (Hepatocellular Carcinoma) Patients Treated With TACE (Transarterial Chemoembolization) and Early, Not Early or Not at All Followed by Sorafenib https://ClinicalTrials.gov/show/NCT01933945 Completed Bayer 2017-07-22
NCT01908322 Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety https://ClinicalTrials.gov/show/NCT01908322 Completed Bayer 2015-06-30
NCT01904942 Study of Hepatocellular Carcinoma in Cirrhotic Patients https://ClinicalTrials.gov/show/NCT01904942 Completed Centre Hospitalier Universitaire Dijon 2010-06-30
NCT01839630 Sorafenib Concomitantly Used With TACE (Transarterial Chemoembolization) in uHCC (Unresectable Hepatocellular Carcinoma) Patients in China https://ClinicalTrials.gov/show/NCT01839630 Completed Bayer 2016-08-06
NCT01825213 Stratification of Patients With Chronic Liver Disease Using Multi Spectral CT https://ClinicalTrials.gov/show/NCT01825213 Completed Massachusetts General Hospital 2016-10-31
NCT01786980 The Methylation Phenotype Screening and Determination Mode Study of Liver Cancer Prognosis Related Gene https://ClinicalTrials.gov/show/NCT01786980 Completed Eastern Hepatobiliary Surgery Hospital 2015-12-31
NCT01777698 Body Composition Analysis in Patients Undergoing Chemoembolization https://ClinicalTrials.gov/show/NCT01777698 Completed Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 2015-08-31
NCT01751763 Sorafenib for Residue Disease After Resection With Curative Intent https://ClinicalTrials.gov/show/NCT01751763 Completed Bayer 2016-12-31
NCT03349957 TACE for HCC by TANDEM and Idarubicin https://ClinicalTrials.gov/show/NCT03349957 Completed University Hospital, Montpellier 2018-01-30
NCT01657695 Hepatocellular Carcinoma Growth and Molecular Aggressiveness https://ClinicalTrials.gov/show/NCT01657695 Completed University of Modena and Reggio Emilia 2012-05-31
NCT01619475 Adult-to-Adult Living Donor Transplant Cohort Study https://ClinicalTrials.gov/show/NCT01619475 Completed Arbor Research Collaborative for Health 2014-08-31
NCT01549275 Primary Cell Culture of Hepatic Tumorous Cells From Routine Fine-needle Aspiration https://ClinicalTrials.gov/show/NCT01549275 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2013-01-31
NCT01539681 Sorafenib in Hepatocellular Carcinoma Clinical Practice in Italy https://ClinicalTrials.gov/show/NCT01539681 Completed Bayer 2014-01-31
NCT01519232 A Study of Changes in Hepatic Function During Radiation Therapy Using Hepatobiliary Single Photon Emission Tomography (SPECT) https://ClinicalTrials.gov/show/NCT01519232 Completed University of Michigan Rogel Cancer Center 2012-06-30
NCT01520779 Recurrence of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01520779 Completed Ain Shams University 2012-11-30
NCT01490203 Evaluation of Remnant Liver Function Using Primovist-enhanced MRI Before Resection/Ablation of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01490203 Completed Seoul National University Hospital 2014-02-28
NCT01481805 Biomarker Analysis in Sorafenib Treated Hepatocellular Carcinoma Patients https://ClinicalTrials.gov/show/NCT01481805 Completed Samsung Medical Center 2014-01-13
NCT01482520 Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma https://ClinicalTrials.gov/show/NCT01482520 Completed Samsung Medical Center 2013-09-30
NCT01473121 Hepatocellular Carcinoma Registry for Turkey (3K Trial) https://ClinicalTrials.gov/show/NCT01473121 Completed Bayer 2017-06-30
NCT01474694 Accuracy Assessment for Computer-assisted Surgical Interventions of the Liver https://ClinicalTrials.gov/show/NCT01474694 Completed University Hospital Inselspital, Berne 2013-12-31
NCT01446666 Gadoxetic Acid-MRI Versus Ultrasonography for the Surveillance of Hepatocellular Carcinoma in High-risk Patients https://ClinicalTrials.gov/show/NCT01446666 Completed Asan Medical Center 2014-12-31
NCT01416714 Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy https://ClinicalTrials.gov/show/NCT01416714 Recruiting University of Chicago 2025-01-31
NCT01411579 Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma https://ClinicalTrials.gov/show/NCT01411579 Completed University of Florence 2012-02-29
NCT01411436 Nexavar Post-marketing Surveillance for Hepatocellular Carcinoma in Japan https://ClinicalTrials.gov/show/NCT01411436 Completed Bayer 2014-03-31
NCT01360255 AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) https://ClinicalTrials.gov/show/NCT01360255 Completed University Hospital Freiburg 2015-11-30
NCT01361061 AFP - L3% and DCP as Screening Marker for a Hepatocellular Carcinoma in Patients With Cirrhosis of the Liver https://ClinicalTrials.gov/show/NCT01361061 Completed University Hospital Freiburg 2015-11-30
NCT01355107 Comparison of Selenium Levels in HCV- Infected Patients at Different Stages of Disease https://ClinicalTrials.gov/show/NCT01355107 Completed University Hospital Freiburg 2011-12-31
NCT01349075 TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01349075 Recruiting Thomas Jefferson University 2020-12-31
NCT03233360 Hepatocellular Carcinoma Registry in Asia https://ClinicalTrials.gov/show/NCT03233360 Recruiting National Cancer Centre, Singapore 2022-03-31
NCT04412161 Liver Transplant for Larger Hepatocellular Carcinoma in Malatya: The Role of GGT and AFP https://ClinicalTrials.gov/show/NCT04412161 Completed Inonu University 2019-01-01
NCT04371042 PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies https://ClinicalTrials.gov/show/NCT04371042 Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2035-12-31
NCT04367805 COVID-19 Infection in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04367805 Recruiting Centre Hospitalier Universitaire, Amiens 2020-10-31
NCT04348838 Prospective Cohort of Patients With Hepatocellular Carcinoma in France https://ClinicalTrials.gov/show/NCT04348838 Recruiting Centre Hospitalier Universitaire, Amiens 2027-09-30
NCT04315883 Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors https://ClinicalTrials.gov/show/NCT04315883 Recruiting Nemours Children’s Clinic 2029-03-01
NCT04303286 The Effect of Gut Microbiota on Postoperative Liver Function Recovery in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04303286 Recruiting Tongji Hospital 2020-05-31
NCT04299919 The AI Prognostic Assessment and Pathological Basis Research of Early HCC After Minimally Invasive Treatment https://ClinicalTrials.gov/show/NCT04299919 Active, not recruiting The First Affiliated Hospital of Dalian Medical University 2023-06-30
NCT04296058 The Mechanism of Sox4 Transcription in Regulation of Angiogenesis in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04296058 Completed Chang Gung Memorial Hospital 2019-03-31
NCT04264754 Characterization of Methylation Patterns in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04264754 Recruiting Nucleix Ltd. 2024-12-31
NCT04239781 A Survey for Factors That Influence Postoperative Treatment Decision-making for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04239781 Recruiting Shanghai Zhongshan Hospital 2020-06-30
NCT04221347 Novel Molecular Spectrometric Biomarkers in Blood Plasma as an Early Diagnostic Tool in HCC https://ClinicalTrials.gov/show/NCT04221347 Recruiting Military University Hospital, Prague 2020-12-31
NCT04209491 Interest of the Intervention of a Nurse Coordinator in Complex Care Pathway https://ClinicalTrials.gov/show/NCT04209491 Recruiting Assistance Publique - Hôpitaux de Paris 2020-02-01
NCT04189809 Discrepancies in Management of Hepatocellualr Carcinoma Between Practice and Recommendations https://ClinicalTrials.gov/show/NCT04189809 Active, not recruiting University Hospital, Montpellier 2020-03-01
NCT04177316 Hypermethylation of VTRNA2-1 Promoter in HCC Outcome https://ClinicalTrials.gov/show/NCT04177316 Completed Chang Gung Memorial Hospital 2019-11-15
NCT04172194 Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas https://ClinicalTrials.gov/show/NCT04172194 Completed Centre Hospitalier Universitaire de Nice 2014-12-31
NCT04163627 Changing Trends in HCC Procedures https://ClinicalTrials.gov/show/NCT04163627 Recruiting University Hospital, Montpellier 2021-03-01
NCT04161287 Comparison of Efficacy in SBRT of HCC ≤5 cm With or Without TACE https://ClinicalTrials.gov/show/NCT04161287 Recruiting Beijing 302 Hospital 2022-11-11
NCT04161911 A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy https://ClinicalTrials.gov/show/NCT04161911 Completed Bristol-Myers Squibb 2018-11-15
NCT04160897 Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis https://ClinicalTrials.gov/show/NCT04160897 Enrolling by invitation Ruijin Hospital 2020-10-31
NCT04152356 Combined Immunotherapy and Targeted Therapy for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04152356 Recruiting Guangxi Medical University 2020-08-01
NCT04076631 Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04076631 Recruiting Tongji Hospital 2020-09-30
NCT04021056 Observational Study on Patients With Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT04021056 Recruiting Nanfang Hospital of Southern Medical University 2019-08-31
NCT04008082 A Study of Overall Survival in Participants With Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT04008082 Recruiting Eisai Inc. 2023-05-31
NCT03959800 Molecular Basis of Pediatric Liver Cancer https://ClinicalTrials.gov/show/NCT03959800 Recruiting University of Pittsburgh 2028-06-30
NCT03958669 Fingerprint Characterization of Sorafenib Treated HCC https://ClinicalTrials.gov/show/NCT03958669 Recruiting University Hospital Tuebingen 2021-06-30
NCT03904667 Application of Watson for Oncology in Hepatocellular Carcinoma Surgery https://ClinicalTrials.gov/show/NCT03904667 Active, not recruiting Zhujiang Hospital 2021-12-31
NCT03894917 Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03894917 Recruiting The University of Texas Health Science Center at San Antonio 2020-04-30
NCT03881501 Evaluate the Treatment With Sintilimab Injection Plus Endostar in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03881501 Recruiting Huazhong University of Science and Technology 2020-03-31
NCT03878550 Case-Control Study of the Glycotestâ„¢ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03878550 Recruiting Glycotest, Inc. 2020-12-31
NCT03880721 By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation https://ClinicalTrials.gov/show/NCT03880721 Recruiting Chinese PLA General Hospital 2020-08-31
NCT03852238 Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study) https://ClinicalTrials.gov/show/NCT03852238 Completed University Hospital, Bordeaux 2013-11-14
NCT03804593 HCCBloodTest for Detection of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03804593 Completed Epigenomics, Inc 2019-10-01
NCT03775863 AFP Model and Liver Transplantation. https://ClinicalTrials.gov/show/NCT03775863 Completed Austral University, Argentina 2018-12-12
NCT03767764 Yliver as a Test to Early Diagnose HCC https://ClinicalTrials.gov/show/NCT03767764 Active, not recruiting Corporacion Parc Tauli 2020-04-01
NCT03756051 Harms of Hepatocellular Carcinoma Surveillance https://ClinicalTrials.gov/show/NCT03756051 Active, not recruiting University of Texas Southwestern Medical Center 2022-04-30
NCT03734068 Chemoembolization Using LifePearl Polyethylene Glycol Drug Eluting Microspheres With Doxorubicin in HCC https://ClinicalTrials.gov/show/NCT03734068 Recruiting International Group of Endovascular Oncology 2021-06-30
NCT03707080 Direct Acting Antiviral-Post Authorization Safety Study https://ClinicalTrials.gov/show/NCT03707080 Active, not recruiting Target PharmaSolutions, Inc. 2020-12-31
NCT03702998 Hepatocellular Carcinoma in HIV-infected Individuals in Asian Population https://ClinicalTrials.gov/show/NCT03702998 Recruiting Chinese University of Hong Kong 2020-07-31
NCT03663114 A Post-marketing Observational Study on Risk Factors for Hepatic Encephalopathy in Participants With Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03663114 Active, not recruiting Eisai Inc. 2021-05-31
NCT03630068 Computer-assisted Tumor Ablation for Patients With Liver Cancer https://ClinicalTrials.gov/show/NCT03630068 Completed University Hospital Inselspital, Berne 2017-12-31
NCT03628651 Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03628651 Completed Exact Sciences Corporation 2020-03-11
NCT03612726 The Overall Survival of Patients With Unresectable HCC in Real-life https://ClinicalTrials.gov/show/NCT03612726 Recruiting Humanity & Health Medical Group Limited 2023-07-31
NCT03602703 Immune Responses in Hepatocellular Carcinoma Patients After Treatment With Direct Acting Antiviral Drugs https://ClinicalTrials.gov/show/NCT03602703 Completed Assiut University 2019-09-01
NCT03595345 A Worldwide Score for Hepatocellular Cancer and Liver Transplantation https://ClinicalTrials.gov/show/NCT03595345 Completed European Hepatocellular Cancer Liver Transplant Group 2018-10-15
NCT03588442 Prospective Surveillance for Very Early Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03588442 Recruiting Eastern Hepatobiliary Surgery Hospital 2022-07-15
NCT03551951 Tumor Cell and DNA Detection in the Blood, Urine, and Bone Marrow https://ClinicalTrials.gov/show/NCT03551951 Recruiting University of Missouri-Columbia 2022-06-30
NCT03534843 A Comparison Between Child-Pugh and Albumin-Bilirubin Scores https://ClinicalTrials.gov/show/NCT03534843 Completed Huazhong University of Science and Technology 2015-08-01
NCT03517332 Circulating Tumor DNA Exposure in Peripheral Blood https://ClinicalTrials.gov/show/NCT03517332 Recruiting Quantgene Inc. 2019-12-31
NCT03516890 Management of Spontaneous Ruptured Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03516890 Completed Huazhong University of Science and Technology 2015-06-01
NCT03507140 Microbiota Study in Liver Transplanted Patients https://ClinicalTrials.gov/show/NCT03507140 Recruiting University Hospital, Grenoble 2021-11-01
NCT03483922 HCC Screening Using DNA Methylation Changes in ctDNA https://ClinicalTrials.gov/show/NCT03483922 Recruiting HKGepitherapeutics 2020-06-01
NCT03490461 Effects of Statin on Hepatocellular Carcinoma Recurrence After Liver Transplantation https://ClinicalTrials.gov/show/NCT03490461 Completed Yonsei University 2018-03-01
NCT03476421 R1vascular Hepatectomy for HCC Patients https://ClinicalTrials.gov/show/NCT03476421 Completed Humanitas Clinical and Research Center 2015-12-31
NCT03474354 DC Bead LUMI (TM) Loaded With Doxorubicin for Intermediate Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT03474354 Recruiting University of Athens 2019-12-30
NCT03430635 Role of Choline PET/CT in Predicting Survival in Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03430635 Completed Humanitas Clinical and Research Center 2015-12-31
NCT03428321 Small and Steatotic Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT03428321 Completed University Hospital, Montpellier 2019-11-01
NCT01237132 East-West Hepatocellular Carcinoma Study Group https://ClinicalTrials.gov/show/NCT01237132 Completed University of Milan NA
NCT01213758 Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT https://ClinicalTrials.gov/show/NCT01213758 Completed University of Aarhus 2016-04-30
NCT01034865 Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer https://ClinicalTrials.gov/show/NCT01034865 Completed Stanford University 2009-06-30
NCT01012011 Regulatory Post Marketing Surveillance Study on Nexavar® https://ClinicalTrials.gov/show/NCT01012011 Completed Bayer 2015-01-31
NCT00913757 A Study of Molecular and Genetic Factors for Liver Cancer in the Greater Baltimore Area https://ClinicalTrials.gov/show/NCT00913757 Completed National Institutes of Health Clinical Center (CC) 2020-05-01
NCT00911196 Analysis of Expression of Specific Markers and Their Prognostic Significance in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00911196 Completed GlaxoSmithKline 2009-03-31
NCT00912847 Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00912847 Completed Chinese University of Hong Kong 2004-04-30
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00883454 Estimation of Functional Liver Reserve Using Cholinesterases https://ClinicalTrials.gov/show/NCT00883454 Completed University of Milan NA
NCT00858000 Analysis of Expression of Specific Markers in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00858000 Completed GlaxoSmithKline 2009-12-31
NCT02878109 DCE-MRI for Assessment of Response to TACE of HCC https://ClinicalTrials.gov/show/NCT02878109 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2018-12-31
NCT00834028 Recurrence and Distant Metastases in Hepatocellular Carcinoma Treated by Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT00834028 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-12-31
NCT00827723 Indocyanine Green and Portal Pressure in Viral and Alcoholic Cirrhotic Patients With Hepatocarcinoma https://ClinicalTrials.gov/show/NCT00827723 Completed University of Lausanne Hospitals 2018-02-28
NCT00829335 Anatomical Resection of the Liver for Hepatocellular Carcinoma: a New Ultrasound Guided Approach https://ClinicalTrials.gov/show/NCT00829335 Completed University of Milan 2009-01-31
NCT00825877 Long-term Follow-up of HALT-C Sustained Virological Responders https://ClinicalTrials.gov/show/NCT00825877 Completed National Institutes of Health Clinical Center (CC) NA
NCT04415567 Adjuvant Lenvatinib Prevents Recurrence of High-risk Patients With HBV-related HCC After Liver Transplantation https://ClinicalTrials.gov/show/NCT04415567 Completed Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 2020-03-31
NCT03042520 Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment https://ClinicalTrials.gov/show/NCT03042520 Recruiting Kaohsiung Medical University Chung-Ho Memorial Hospital 2022-09-30
NCT01518829 Procalcitonin in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01518829 Completed Ain Shams University 2012-12-31
NCT00812175 Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib https://ClinicalTrials.gov/show/NCT00812175 Completed Bayer 2012-04-30
NCT03203837 Biomarker Analyses in Hepatocellular Carcinoma (HCC) Patients Treated With TheraSphere® https://ClinicalTrials.gov/show/NCT03203837 Recruiting Northwestern University 2020-05-31
NCT03178409 Combined HCC-MFCCC https://ClinicalTrials.gov/show/NCT03178409 Completed University of Milan 2014-12-31
NCT02834546 Correlation Between Sorafenib Plasma Concentrations, Toxicity and Disease Control Rate in Patients Treated by Sorafenib for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02834546 Completed University Hospital, Bordeaux 2019-03-15
NCT02558205 Correlation Between CT Perfusion and Post Y-90 TARE PET/CT Dosimetry https://ClinicalTrials.gov/show/NCT02558205 Recruiting Rush University Medical Center 2020-07-31
NCT04451603 LiverMultiScan Analysis of MRI Scans in HCC https://ClinicalTrials.gov/show/NCT04451603 Recruiting National Cancer Centre, Singapore 2021-12-31
NCT00792350 INSIGHT - Post Marketing Surveillance https://ClinicalTrials.gov/show/NCT00792350 Completed Bayer 2013-10-31
NCT00769730 Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral Replication https://ClinicalTrials.gov/show/NCT00769730 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2009-02-28
NCT00764140 Tumor Growth Factors in Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00764140 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2010-04-30
NCT00679692 Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease https://ClinicalTrials.gov/show/NCT00679692 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2008-03-31
NCT00630240 Risk Factors for the Leakage of Anticancer Drugs to Systemic Circulation by Transcatheter Arterial Chemoembolization https://ClinicalTrials.gov/show/NCT00630240 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2009-02-28
NCT00629421 Early Screening of Hepatocellular Carcinoma in Cirrhotic Patients: a Prospective Study https://ClinicalTrials.gov/show/NCT00629421 Completed Kaohsiung Medical University Chung-Ho Memorial Hospital 2016-12-31
NCT00605150 HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC https://ClinicalTrials.gov/show/NCT00605150 Completed Atrium Health 2012-07-31
NCT00600522 Alternative Surgical Policy for Central Liver Tumors https://ClinicalTrials.gov/show/NCT00600522 Completed University of Milan 2007-01-31
NCT00373347 Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00373347 Recruiting Stanford University 2020-12-31
NCT00341705 The Second Multicenter Hemophilia Cohort Study https://ClinicalTrials.gov/show/NCT00341705 Completed National Institutes of Health Clinical Center (CC) NA
NCT00178867 A National Registry of Patients With Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT00178867 Completed Vanderbilt University NA
NCT02482259 Assessment of Frailty in Patients With Advanced Hepatocellular Cancers https://ClinicalTrials.gov/show/NCT02482259 Completed Newcastle-upon-Tyne Hospitals NHS Trust 2016-07-19
NCT00096733 Adult-to-Adult Living Donor Liver Transplantation Study https://ClinicalTrials.gov/show/NCT00096733 Completed Arbor Research Collaborative for Health 2010-08-31
NCT00059267 Prevention of Recurrent Hepatitis B After Liver Transplantation https://ClinicalTrials.gov/show/NCT00059267 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2007-11-30

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04460157 Prediction of Liver-related Outcomes After HCV Cure https://ClinicalTrials.gov/show/NCT04460157 Recruiting Hospital Universitario de Valme 2021-05-31
NCT02995096 Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02995096 Completed Rigshospitalet, Denmark 2018-10-31
NCT02973204 Circulating Tumor Cells and Tumor DNA in HCC and NET https://ClinicalTrials.gov/show/NCT02973204 Recruiting University of Aarhus 2019-10-31
NCT02954094 A 5-year Longitudinal Observational Study of the Natural History and Management of Patients With HCC https://ClinicalTrials.gov/show/NCT02954094 Recruiting Target PharmaSolutions, Inc. 2024-10-31
NCT02917759 Liver and Biliary Tumor Tissue Registry https://ClinicalTrials.gov/show/NCT02917759 Recruiting Mayo Clinic 2024-02-29
NCT02908048 Extracellular RNA Markers of Liver Disease and Cancer https://ClinicalTrials.gov/show/NCT02908048 Active, not recruiting Mayo Clinic 2021-07-31
NCT02693847 Natural History of Liver Cirrhosis Diagnosed by Transient Elastography in HIV/HCV-coinfected Patients https://ClinicalTrials.gov/show/NCT02693847 Recruiting Hospital Universitario de Valme 2020-12-31
NCT02551250 Annual MRI Versus Biannual US for Surveillance of Hepatocellular Carcinoma in Liver Cirrhosis https://ClinicalTrials.gov/show/NCT02551250 Active, not recruiting Seoul St. Mary’s Hospital 2019-12-31
NCT02501980 Hepatocellular Cancer (HCC) Screening in Zhongshan City https://ClinicalTrials.gov/show/NCT02501980 Active, not recruiting Zhongshan People’s Hospital, Guangdong, China 2022-01-31
NCT02305459 CIRSE Registry for SIR-Spheres Therapy https://ClinicalTrials.gov/show/NCT02305459 Completed Cardiovascular and Interventional Radiological Society of Europe 2018-01-01
NCT02025842 Hepatitis B Virus HBeAg-negative Genotype D Patients and Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT02025842 Completed Azienda Ospedaliera San Camillo Forlanini 2013-12-31
NCT01891539 Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma https://ClinicalTrials.gov/show/NCT01891539 Recruiting International Group of Endovascular Oncology 2021-09-30
NCT01890291 Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients. https://ClinicalTrials.gov/show/NCT01890291 Completed Green Cross Cell Corporation 2016-01-31
NCT04442334 The European NAFLD Registry https://ClinicalTrials.gov/show/NCT04442334 Recruiting Newcastle University 2030-12-31
NCT04069468 Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC) https://ClinicalTrials.gov/show/NCT04069468 Recruiting Biocompatibles UK Ltd 2024-01-01
NCT03775798 Incidence of de Novo Hepatocellular Carcinoma After Antiviral Agents for HCV. https://ClinicalTrials.gov/show/NCT03775798 Recruiting Austral University, Argentina 2020-12-01
NCT03739164 Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS) https://ClinicalTrials.gov/show/NCT03739164 Enrolling by invitation Florida Hospital Tampa Bay Division 2024-08-01
NCT03695952 A Prospective Cohort Study of Patients With Hepatobiliary Cancer Treated With Immune Checkpoint Inhibitors https://ClinicalTrials.gov/show/NCT03695952 Recruiting Asan Medical Center 2020-07-31
NCT01943318 Boramae Hospital Liver Cirrhosis Patient Cohort Study https://ClinicalTrials.gov/show/NCT01943318 Recruiting Seoul National University Boramae Hospital 2022-10-31